|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0008976,
umls-concept:C0019158,
umls-concept:C0021747,
umls-concept:C0023981,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0035525,
umls-concept:C0087111,
umls-concept:C0205088,
umls-concept:C0524910,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C2003874,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-7-3
|
|
pubmed:abstractText |
To investigate the efficacy of high-dose interferon alpha (IFN-alpha) with or without ribavirin in interferon (IFN) non-responders.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0954-691X
|
|
pubmed:author |
pubmed-author:Austrian Hepatitis Study Group,
pubmed-author:DaunVV,
pubmed-author:FerenczAA,
pubmed-author:FickertPP,
pubmed-author:GanglAA,
pubmed-author:GschwantlerMM,
pubmed-author:HacklFF,
pubmed-author:KrejsG JGJ,
pubmed-author:LinWW,
pubmed-author:MüllerCC,
pubmed-author:RainesTT,
pubmed-author:StauberRR,
pubmed-author:Steindl-MundaPP,
pubmed-author:Watkins-RiedelTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
699-705
|
|
pubmed:dateRevised |
2009-10-16
|
|
pubmed:meshHeading |
pubmed-meshheading:11434597-Adult,
pubmed-meshheading:11434597-Aged,
pubmed-meshheading:11434597-Antiviral Agents,
pubmed-meshheading:11434597-Base Sequence,
pubmed-meshheading:11434597-Dose-Response Relationship, Drug,
pubmed-meshheading:11434597-Drug Therapy, Combination,
pubmed-meshheading:11434597-Female,
pubmed-meshheading:11434597-Follow-Up Studies,
pubmed-meshheading:11434597-Hepatitis C, Chronic,
pubmed-meshheading:11434597-Humans,
pubmed-meshheading:11434597-Interferon-alpha,
pubmed-meshheading:11434597-Interferons,
pubmed-meshheading:11434597-Male,
pubmed-meshheading:11434597-Middle Aged,
pubmed-meshheading:11434597-Molecular Sequence Data,
pubmed-meshheading:11434597-Organization and Administration,
pubmed-meshheading:11434597-Polymerase Chain Reaction,
pubmed-meshheading:11434597-Probability,
pubmed-meshheading:11434597-Prospective Studies,
pubmed-meshheading:11434597-RNA, Viral,
pubmed-meshheading:11434597-Reference Values,
pubmed-meshheading:11434597-Ribavirin,
pubmed-meshheading:11434597-Treatment Failure,
pubmed-meshheading:11434597-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group.
|
|
pubmed:affiliation |
Department of Internal Medicine IV, University of Vienna, Austria. peter.ferenci@akh-wien.ac.at
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
